Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Costentin

Showing results (171-180 of 244) with videos related to

Pageof 25
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitorJ Garcia de Mateos-Verchere, J M Vaugeois, B Naudin, et al.
European Journal of Pharmacology|August 25, 1992
JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouseI Dubuc, J Costentin, S Doulut, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaineD Boulay, D Duterte-Boucher, I Leroux-Nicollet, et al.
Synapse (New York, N.Y.)|September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complexL Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Life Sciences|October 30, 1978
Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidolJ C Schwartz, M Baudry, M P Martres, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 9, 2005
Binding of endomorphin-2 to mu-opioid receptors in experimental mouse mammary adenocarcinomaJ Fichna, J-C do-Rego, M Mirowski, et al.
Neuropharmacology|March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brainC Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Journal of Neurochemistry|November 1, 1992
Investigations about a direct neurotensin-dopamine interaction by nuclear magnetic resonance study, synaptosomal uptake of dopamine, and binding of neurotensin to its receptorsD Nouel, J Costentin, D Lugrin, et al.
European Journal of Pharmacology|June 22, 1988
Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitorsI Dubuc, D Nouel, A Coquerel, et al.
Peptides|January 1, 1996
A proenkephalin A-derived peptide analogous to bovine adrenal peptide E from frog brain: purification, synthesis, and behavioral effectsJ M Conlon, N Chartrel, J Leprince, et al.
Pageof 25

Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitorJ Garcia de Mateos-Verchere, J M Vaugeois, B Naudin, et al.
European Journal of Pharmacology|August 25, 1992
JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouseI Dubuc, J Costentin, S Doulut, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaineD Boulay, D Duterte-Boucher, I Leroux-Nicollet, et al.
Synapse (New York, N.Y.)|September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complexL Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Life Sciences|October 30, 1978
Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidolJ C Schwartz, M Baudry, M P Martres, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 9, 2005
Binding of endomorphin-2 to mu-opioid receptors in experimental mouse mammary adenocarcinomaJ Fichna, J-C do-Rego, M Mirowski, et al.
Neuropharmacology|March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brainC Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Journal of Neurochemistry|November 1, 1992
Investigations about a direct neurotensin-dopamine interaction by nuclear magnetic resonance study, synaptosomal uptake of dopamine, and binding of neurotensin to its receptorsD Nouel, J Costentin, D Lugrin, et al.
European Journal of Pharmacology|June 22, 1988
Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitorsI Dubuc, D Nouel, A Coquerel, et al.
Peptides|January 1, 1996
A proenkephalin A-derived peptide analogous to bovine adrenal peptide E from frog brain: purification, synthesis, and behavioral effectsJ M Conlon, N Chartrel, J Leprince, et al.
Pageof 25